The Role of Academic Medical Centers in Personalized Experimental Therapeutic Development
Kira A. Dies(Boston Children's Hospital), Kerri O. Kennedy(Boston Children's Hospital), David K. Urion(Harvard University), A. Beggs(Boston Children's Hospital), Nancy L. Chamberlin(Sankt Hans Hospital), S. L. Pomeroy(Boston Children's Hospital), Judith C. Fleming(Boston Children's Hospital)
Cited by 1
Related Papers
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|808
Growth Attenuation Therapy: Ongoing Ethical and Practical Challenges 20 Years Post Ashley
|The American Journal of Bioethics|2025|8
Pediatric Ethics Consultation: Practical Considerations for the Clinical Ethics Consultant
|The Journal of Clinical Ethics|2019|6
The Complicated Legacy of Cassandra Callender
|JAMA Pediatrics|2020|5
Potentially Inappropriate Treatment: Competing Ethical Considerations
|AACN Advanced Critical Care|2023|3